Instrumentation Laboratory Markets Solution to Test for Rivaroxaban

Instrumentation Laboratory has launched its HemosIL rivaroxaban testing solution in Europe following receipt of the CE mark for in vitro diagnostic medical devices.

The Hemos IL, when used with the company’s calibrators and controls, automatically measures rivaroxaban, an anticoagulant marketed as Xarelto by Bayer HealthCare.

The company says that while monitoring is not required for patients using direct oral anticoagulants such as Xarelto, there are exceptions where it would be beneficial. Those exceptions include patients who are bleeding, require reversal of anticoagulation or require surgery or an invasive procedure and have taken the drug within 24 hours.

Hemos IL provides a consistent, efficient and accurate test to aid patients and their healthcare providers in these situations, the Bedford, Mass, company says. — John Bechtel